Quarterly Results

  • Company Name :
Concord Biotech Ltd Industry : (Pharmaceuticals)
  • BSE Code:
  • 543960
  • NSE Symbol:
  • CONCORDBIO
  • P/E(TTM):
  • 49.06
  • ISIN Demat:
  • INE338H01029
  • Div & Yield%:
  • 0.57
  • EPS(TTM):
  • 31.38
  • Book Value(₹):
  • 152.04
  • Market Cap(₹Cr.):
  • 16,107.23
  • Face Value(₹):
  • 1.00
Quarters :  
Particulars December 2024 ( Cr)September 2024 ( Cr)June 2024 ( Cr)
Gross Sales 244.22 310.18 215.80
Excise Duty 0.00 0.00 0.00
Net Sales 244.22 310.18 215.80
Other Operating Income 0.00 0.00 0.00
Other Income 14.73 10.03 10.31
Total Income 258.95 320.21 226.11
Total Expenditure 146.27 173.50 134.52
PBIDT 112.68 146.70 91.59
Interest 0.10 0.10 0.24
PBDT 112.58 146.61 91.35
Depreciation 13.26 13.31 13.18
Tax 23.69 34.06 19.39
Fringe Benefit Tax 0.00 0.00 0.00
Deferred Tax 1.54 0.53 0.53
Reported Profit After Tax 74.09 98.70 58.24
Extra-ordinary Items 0.00 0.00 0.00
Adjusted Profit After Extra-ordinary item 74.09 98.70 58.24
EPS (Unit Curr.) 7.08 9.43 5.57
EPS (Adj) (Unit Curr.) 7.08 9.43 5.57
Calculated EPS (Unit Curr.) 7.08 9.43 5.57
Calculated EPS (Adj) (Unit Curr.) 7.08 9.43 5.57
Calculated EPS (Ann.) (Unit Curr.) 28.33 37.74 22.27
Calculated EPS (Adj) (Ann.) (Unit Curr.) 28.33 37.74 22.27
Book Value (Unit Curr.) 0.00 0.00 0.00
Dividend (%) 0.00 0.00 0.00
Equity 10.46 10.46 10.46
Reserve & Surplus 0.00 0.00 0.00
Face Value 1.00 1.00 1.00
Public Shareholding (No. Of Shares) 0.00 0.00 0.00
Public Shareholding (% in Equity) 0.00 0.00 0.00
Pledged/Encumbered - No. of Shares 0.00 0.00 0.00
Pledged/Encumbered - % in Total Promoters Holding 0.00 0.00 0.00
Pledged/Encumbered - % in Total Equity 0.00 0.00 0.00
Non Encumbered - No. of Shares 0.00 0.00 0.00
Non Encumbered - % in Total Promoters Holding 0.00 0.00 0.00
Non Encumbered - % in Total Equity 0.00 0.00 0.00
PBIDTM(%) 46.14 47.30 42.44
PBDTM(%) 46.10 47.27 42.33
PATM(%) 30.34 31.82 26.99